Aditya Halthore, MD, serves as Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and Director of Safety and Quality at the Johns Hopkins University School of Medicine. Listen to Dr. Halthore's On Target podcast episode to learn more about his work. Dr. Halthore is an expert in proton therapy and specializes in genitourinary and thoracic cancers. His specific interests include prostate, bladder, lung, esophageal, and thymic cancers, and he is committed to developing personalized treatment strategies for every patient. Dr. Halthore was previously recognized as a Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Scholar and his research interests include grant funded clinical trials focused on the novel utilization of radiation and imaging techniques, such as spatial fractionation (proton GRID) therapy for the treatment of bulky cancers. He is also involved in using dual-energy CT and functional MRI studies that aim to improve functional radiation planning and the assessment of radiation-induced changes. As an educator, Dr. Halthore serves as Course Director for the Johns Hopkins Proton Therapy Certificate Program. He actively participates in student, resident, and fellow lectureship and mentorship across the Johns Hopkins health system. Dr. Halthore participates in several national-level initiatives including as a member of the American Society of Therapeutic Radiation Oncology (ASTRO) Guidelines Subcommittee and as a board member and ASTRO liaison to the Medical Dosimetry Certification Board (MDCB). Dr. Halthore is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Prostate Cancer, Small Cell Lung Cancer (SCLC), Marginal Zone Lymphoma (MZL), and Familial Prostate Cancer.

Marie Kate Gurka, M.D., is a radiation oncologist in the Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Gurka has expertise in radiation treatment for breast cancer and gynecologic cancers. Dr. Gurka earned her medical degree from Virginia Commonwealth University and completed a residency in radiation oncology at Georgetown University Hospital. She previously served as an instructor in the Department of Radiation Oncology at University of Louisville and has conducted both clinical and basic science research. Her work has been recognized by the American Society for Radiation Oncology (ASTRO), and the American Society of Clinical Oncology (ASCO), and it has been cited in various lectures, research articles, and textbooks. Washingtonian Magazine and Bethesda Magazine have repeatedly named Dr. Gurka a Top Doctor. Selected Publications Oermann EK, Bhandari R, Chen V, Lebec G, Gurka M, Lei S, Chen L, Suy, S, Azumi N, Berkowitz F, Kalhorn C, McGrail K, Collins BT, Jean W, Collins SP. Five Fraction Image-Guided Radiosurgery for Primary and Recurrent Meningiomas. Frontiers in Radiation Oncology. 2013; 3: 213. Gurka MK, Collins SP, Slack R, Tse G, Charabaty A, Ley L, Berzcel L, Lei S, Suy S, Haddad N, Jha R, Johnson CD, Jackson P, Marshall JL, Pishvaian MJ. Stereotactic Body Radiation Therapy with Concurrent Full-Dose Gemcitabine for Locally Advanced Pancreatic Cancer: A Pilot Trial Demonstrating Safety. Radiation Oncology. 2013; 8: 44. Gurka MK, Kim C , Carroll J, Charabaty A, Haddad M, Jackson P, Collins SP, Marshall J, Pishvaian MK, Unger KR. Stereotactic Body Radiation Therapy (SBRT) combined with chemotherapy for unresected pancreatic adenocarcinoma. American Journal of Clinical Oncology. 2014; 152-157. Gurka MK, Horne ZD, Ju A, Chen L, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Suy S, Dritschilo A, Lynch JH, Collins SP. Hematuria Following Stereotactic Body Radiation Therapy (SBRT) for Clinically Localized Prostate Cancer. Radiation Oncology. 2015; 10:44. Gurka MK, Pender D, Chuong P, Fouts B, Sebelov A, McNally M, Mezera M, Woo SY, McNally R. Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. Journal of Controlled Release. 2016; 231:60-67. Dr. Gurka is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Breast Cancer, Intraductal Papilloma, Gliomatosis Cerebri, and Marginal Zone Lymphoma (MZL).

Danielle Shafer is an Oncologist and a Hematologist in Falls Church, Virginia. Dr. Shafer is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Myringotomy. Dr. Shafer is currently accepting new patients.

Robert Reid is a Hematologist and an Oncologist in Fairfax, Virginia. Dr. Reid is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Xiaojun Wu, M.D., Ph.D. is as assistant professor of pathology at Sibley Memorial Hospital where she will lead their hematopathology program. Dr. Wu received her M.D. from Zhejiang Medical University in China, and her Ph.D. from the University of Alabama at Birmingham. She continued at the University of Alabama at Birmingham for pathology residency training, followed by a fellowship in hematopathology. She then moved to New York where she completed a surgical pathology fellowship at Memorial Sloan Kettering Cancer Center. She subsequently joined the faculty at New York University from 2013-2015 and moved to the Washington area in 2015 and joined the faculty at George Washington University from 2015-2016. She has been with Johns Hopkins since 2016. Dr. Wu has 15 peer-reviewed publications, primarily in the field of hematopathology. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Acute Myeloid Leukemia (AML).

Michael N. Solomon, M.D., is a pulmonologist with Johns Hopkins Medicine Pulmonology. Dr. Solomon has expertise in chronic obstructive pulmonary disease, asthma, lung cancer, pleural diseases, interstitial lung disease and bronchiectasis. Dr. Solomon earned his medical degree from the University of Massachusetts Medical School. He completed a residency in internal medicine at Georgetown University Medical Center, followed by a fellowship in pulmonary diseases and critical care medicine at Georgetown University Medical Center as well. Dr. Solomon has been named annually a Top Doctor in the Washington, D.C. area since 2005. Dr. Solomon is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Bronchiectasis, Lung Metastases, Pneumonia, and Nontuberculous Mycobacterial Lung Disease.

Catherine Broome is a Hematologist in Washington, Washington, D.c.. Dr. Broome is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Autoimmune Hemolytic Anemia, Chronic B-Cell Leukemia (CBCL), Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Victoria J. Croog, M.D., Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Croog has expertise in breast cancer, gastrointestinal cancer, gynecologic cancer, brain cancer and tumors of the central nervous system. Dr. Croog earned her medical degree from Harvard Medical School. She completed an internship and a residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. Dr. Croog is involved with several committees at Sibley Memorial Hospital, including the Medical Executive Committee, the IRB/Research Review Committee, the Cancer Committee and the Radiation Safety Committee. She is also a member of the American Society of Clinical Oncology and the American Society of Radiation Oncology. Dr. Croog has been repeatedly named a Top Doctor by Washingtonian Magazine. Dr. Croog has been published in numerous peer-reviewed journals and has presented research at various conferences, such as the American Society of Clinical Oncology’s annual meeting. Make A Gift LinkedIn https://www.linkedin.com/in/victoria-croog-88a31759. Dr. Croog is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Gliosarcoma, Astrocytoma, Posterior Fossa Tumor, and Endometrial Cancer.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Keeran Sampat is a Hematologist and an Oncologist in Arlington, Virginia. Dr. Sampat is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Anal Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Paget Disease of the Breast.

Stella Hetelekidis is a Radiation Oncologist in Fairfax, Virginia. Dr. Hetelekidis is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Breast Cancer, Endometrial Cancer, Angiosarcoma, and HER-2 Positive Breast Cancer. Dr. Hetelekidis is currently accepting new patients.

Sarah Gao is a Radiologist and a Radiation Oncologist in Fairfax, Virginia. Dr. Gao is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are HER-2 Positive Breast Cancer, Metastatic Brain Tumor, Familial Prostate Cancer, Prostate Cancer, and Lymphadenectomy. Dr. Gao is currently accepting new patients.

Raymund Cuevo is an Oncologist and a Hematologist in Fairfax, Virginia. Dr. Cuevo is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Myelodysplastic Syndrome (MDS), Burkitt Lymphoma, Acute Myeloid Leukemia (AML), Lung Cancer, and Bone Marrow Aspiration. Dr. Cuevo is currently accepting new patients.

Richard Rizzo is a Radiologist in Fairfax, Virginia. Dr. Rizzo is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Visceromegaly, Splenomegaly, Folliculitis, and Boils. Dr. Rizzo is currently accepting new patients.

Avani Rao is a Radiation Oncologist in Fairfax, Virginia. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Endometrial Stromal Sarcoma, Endometrial Cancer, Metastatic Brain Tumor, and Familial Prostate Cancer. Dr. Rao is currently accepting new patients.

Christopher Johnson is a Radiation Oncologist in Fairfax, Virginia. Dr. Johnson has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Metastatic Brain Tumor, Pleuropulmonary Blastoma, Lung Cancer, and Familial Prostate Cancer. Dr. Johnson is currently accepting new patients.

Daniel Kim is a Radiation Oncologist in Fairfax, Virginia. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, Brain Tumor, and Prostatectomy. Dr. Kim is currently accepting new patients.

Mustafa Abugideiri is a Radiation Oncologist in Fairfax, Virginia. Dr. Abugideiri is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer. Dr. Abugideiri is currently accepting new patients.

Aaron Stack is a Nuclear Medicine specialist and a Radiologist in Annandale, Virginia. Dr. Stack is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Primary Lymphoma of the Brain, Classical Hodgkin Lymphoma, Neuroendocrine Tumor, and Lung Nodules.